Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Cooper

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Adaptive control with feedback strategies for suramin dosingM R Cooper, R Lieberman, R V La Rocca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancerA Thibault, D Samid, A C Tompkins, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Cancer|June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
Cancer|June 15, 1981
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology AssociationF Richards, V Howard, A Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancerN A Dawson, W D Figg, M R Cooper, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Adaptive control with feedback strategies for suramin dosingM R Cooper, R Lieberman, R V La Rocca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancerA Thibault, D Samid, A C Tompkins, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Cancer|June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
Cancer|June 15, 1981
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology AssociationF Richards, V Howard, A Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancerN A Dawson, W D Figg, M R Cooper, et al.
Pageof 25